Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-08

Clinical Trial Update: Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating dexamethasone to reduce macular thickness in diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Universidade Federal de Pernambuco | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2019-10-08